Wealth Enhancement Advisory Services
BMRN icon

Wealth Enhancement Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$4.28M Buy
74,381
+29,797
+67% +$1.71M 0.01% 964
2025
Q1 		$3.15M Buy
44,584
+21,383
+92% +$1.51M 0.01% 1024
2024
Q4 		$1.53M Buy
23,201
+17,340
+296% +$1.14M ﹤0.01% 1308
2024
Q3 		$412K Buy
5,861
+2,289
+64% +$161K ﹤0.01% 1941
2024
Q2 		$294K Buy
+3,572
New +$294K ﹤0.01% 1992